S.3564

NIH Clinical Trial Integrity Act aims to enhance diversity in clinical trials funded by the National Institutes of Health.

The NIH Clinical Trial Integrity Act mandates that clinical trials funded by the National Institutes of Health (NIH) set clear diversity goals for participant recruitment and retention. These goals should reflect the race, ethnicity, age, and sex of patients with the disease or condition being investigated or, if prevalence is unknown, the general U.S. population. NIH-funded research organizations must submit applications detailing their plans to achieve these goals, including strategies for enrolling and retaining participants from diverse backgrounds.